BA225

N/A

Report date: 2025/11/17 15:19:54

Base Information

Drug NameBA225
Drug Alias NameBA225BA-225
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 modulators
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesT-Cypher Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesT-Cypher Bio Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A